793 related articles for article (PubMed ID: 36190593)
21. Basic research in PCOS: are we reaching new frontiers?
Ben-Shlomo I; Younis JS
Reprod Biomed Online; 2014 Jun; 28(6):669-83. PubMed ID: 24768413
[TBL] [Abstract][Full Text] [Related]
22. OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome.
Rudnicka E; Duszewska AM; Kucharski M; Tyczyński P; Smolarczyk R
Reproduction; 2022 Dec; 164(6):F145-F154. PubMed ID: 36279177
[TBL] [Abstract][Full Text] [Related]
23. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
24. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.
McGee WK; Bishop CV; Bahar A; Pohl CR; Chang RJ; Marshall JC; Pau FK; Stouffer RL; Cameron JL
Hum Reprod; 2012 Feb; 27(2):531-40. PubMed ID: 22114112
[TBL] [Abstract][Full Text] [Related]
25. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS).
Garg A; Patel B; Abbara A; Dhillo WS
Clin Endocrinol (Oxf); 2022 Aug; 97(2):156-164. PubMed ID: 35262967
[TBL] [Abstract][Full Text] [Related]
26. Polycystic ovary syndrome.
Joham AE; Norman RJ; Stener-Victorin E; Legro RS; Franks S; Moran LJ; Boyle J; Teede HJ
Lancet Diabetes Endocrinol; 2022 Sep; 10(9):668-680. PubMed ID: 35934017
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
28. The interplay between androgens and the immune response in polycystic ovary syndrome.
Shabbir S; Khurram E; Moorthi VS; Eissa YTH; Kamal MA; Butler AE
J Transl Med; 2023 Apr; 21(1):259. PubMed ID: 37062827
[TBL] [Abstract][Full Text] [Related]
29. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.
Seow KM; Chang YW; Chen KH; Juan CC; Huang CY; Lin LT; Tsui KH; Chen YJ; Lee WL; Wang PH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142702
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine Determinants of Polycystic Ovary Syndrome.
Szeliga A; Rudnicka E; Maciejewska-Jeske M; Kucharski M; Kostrzak A; Hajbos M; Niwczyk O; Smolarczyk R; Meczekalski B
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270780
[TBL] [Abstract][Full Text] [Related]
32. Genetic, hormonal and metabolic aspects of PCOS: an update.
De Leo V; Musacchio MC; Cappelli V; Massaro MG; Morgante G; Petraglia F
Reprod Biol Endocrinol; 2016 Jul; 14(1):38. PubMed ID: 27423183
[TBL] [Abstract][Full Text] [Related]
33. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
34. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
36. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
37. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
38. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
39. [Mechanism of mitochondrial dysfunction in polycystic ovary syndrome and traditional Chinese medicine intervention: a review].
Lu LJ; Zhang J; Jiang Y; Han YH; Zhang YH
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):1-14. PubMed ID: 38403333
[TBL] [Abstract][Full Text] [Related]
40. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
Otto-Buczkowska E; Grzyb K; Jainta N
Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
